Year 2020 / Volume 112 / Number 3
Letter
Rhabdomyolysis in a patient under treatment with sorafenib

243-244

DOI: 10.17235/reed.2020.6440/2019

María del Mar Díaz Alcázar, Eloísa Cervilla Sáez de Tejada, Elena Ruiz Escolano,

Abstract
We present a case of rhabdomyolysis related to treatment with sorafenib in a patient with multifocal hepatocellular carcinoma. Rhabdomyolysis is a severe situation and potentially fatal. There are no laboratory data that can predict this condition. Early diagnosis is essential for prognosis. Rhabdomyolysis has been described as an adverse reaction of several drugs but it is not frequently related to sorafenib.
Share Button
New comment
Comments

21/08/2024 4:44:30
none


References
1. Hohenegger M. Drug induced rhabdomyolysis. Curr Opin Pharmacol 2012;12:335–9.
2. Tsuji K, Takemura K, Minami K, Teramoto R, Nakashima K, Yamada S, et al. A case of rhabdomyolysis related to sorafenib treatment for advanced hepatocellular carcinoma. Clin J Gastroenterol 20136:255–7.
3. Antoun S, Birdsell L, Sawyer MB, Venner P, Escudier B, Baracos VE. Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study. J Clin Oncol 2010;28(6):1054-60.
Related articles

Editorial

Hemophilia and hepatology, back to the future

DOI: 10.17235/reed.2024.10105/2023

Digestive Diseases Image

Giant cystic hepatocarcinoma in the absence of cirrhosis

DOI: 10.17235/reed.2021.8313/2021

Letter

Biopsy for hepatocellular carcinoma: only occasionally

DOI: 10.17235/reed.2020.6935/2020

Letter

Hepatocarcinoma diagnosis. Reflection is required

DOI: 10.17235/reed.2020.6845/2019

Case Report

Ectopic hepatocellular carcinoma arising from the peritoneum

DOI: 10.17235/reed.2019.6408/2019

Digestive Diseases Image

Debut of an unusual liver cirrhosis

Review

New challenges in clinical research on hepatocellular carcinoma

DOI: 10.17235/reed.2015.4012/2015

Citation tools
Díaz Alcázar M, Cervilla Sáez de Tejada E, Ruiz Escolano E. Rhabdomyolysis in a patient under treatment with sorafenib. 6440/2019


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1143 visits.
This article has been downloaded 152 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 10/06/2019

Accepted: 16/06/2019

Online First: 21/01/2020

Published: 05/03/2020

Article Online First time: 225 days

Article editing time: 269 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology